For research use only. Not for therapeutic Use.
CB30865（Cat No.:I002587）is a small molecule inhibitor that targets the protein kinase CK2 (casein kinase 2), a serine/threonine kinase involved in regulating various cellular processes, including cell proliferation, survival, and differentiation. CK2 is often overactive in cancers and other diseases, making it a potential therapeutic target. By inhibiting CK2, CB30865 may help reduce tumor cell growth and enhance the effects of other anticancer treatments. It has shown promise in preclinical studies as a potential treatment for cancer and other diseases with dysregulated CK2 activity, although further research is needed to assess its clinical efficacy and safety.
| Catalog Number | I002587 |
| CAS Number | 206275-15-2 |
| Synonyms | 4-[(7-bromo-2-methyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-(pyridin-3-ylmethyl)benzamide |
| Molecular Formula | C26H22BrN5O2 |
| Purity | ≥95% |
| Target | NAMPT |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20°C |
| IUPAC Name | 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-(pyridin-3-ylmethyl)benzamide |
| InChI | InChI=1S/C26H22BrN5O2/c1-3-11-32(16-20-12-22-24(13-23(20)27)30-17(2)31-26(22)34)21-8-6-19(7-9-21)25(33)29-15-18-5-4-10-28-14-18/h1,4-10,12-14H,11,15-16H2,2H3,(H,29,33)(H,30,31,34) |
| InChIKey | SHNBLWMBWXIKMR-UHFFFAOYSA-N |
| SMILES | CC1=NC2=C(C=C(C(=C2)Br)CN(CC#C)C3=CC=C(C=C3)C(=O)NCC4=CN=CC=C4)C(=O)N1 |
| Reference | </br>1:Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. Fleischer TC, Murphy BR, Flick JS, Terry-Lorenzo RT, Gao ZH, Davis T, McKinnon R, Ostanin K, Willardsen JA, Boniface JJ.Chem Biol. 2010 Jun 25;17(6):659-64. doi: 10.1016/j.chembiol.2010.05.008. PMID: 20609415 Free Article</br>2:The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent. Bavetsias V, Skelton LA, Yafai F, Mitchell F, Wilson SC, Allan B, Jackman AL.J Med Chem. 2002 Aug 15;45(17):3692-702. PMID: 12166942 </br>3:Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action. Skelton LA, Ormerod MG, Titley JC, Jackman AL.Cytometry. 1998 Sep 1;33(1):56-66. PMID: 9725559 |
